Literature DB >> 3785437

Dose-dependent effects of isosorbide-5-mononitrate on the venous, arterial and coronary arterial system of conscious dogs.

E Bassenge, K Strein.   

Abstract

Isosorbide-5-mononitrate (IS-5-MN), the main metabolite of isosorbide dinitrate shows antianginal efficacy and is being used increasingly as a drug for practical therapy. In conscious dogs we therefore measured the effects of increasing doses of IS-5-MN on hemodynamic parameters and the diameter of the circumflex artery. We found a dose dependent reduction of the mean right atrial pressure, the systolic blood pressure and a dilatation of the circumflex artery. For all three parameters threshold dosages were between 0.01 and 0.03 mg/kg. On the contrary peripheral and coronary resistance did not change at doses less than or equal to 0.3 mg/kg. The heart rate was significantly increased only at doses above 1 mg/kg and the diastolic blood pressure also showed a tendency to fall only at doses above 1 mg/kg. Cardiac output and coronary flow were not significantly altered over the entire dose range investigated, with the exception of a transient rise in coronary blood flow after the injection of 2.5 mg/kg IS-5-MN. From our results we can deduce that in the low dose range reduction of preload and dilatation of large arteries are the main effects of IS-5-MN. In contrast, no reduction of the coronary or peripheral resistance is to be expected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3785437     DOI: 10.1007/bf00498746

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  6 in total

1.  Effects of nitrates in various vascular sections and regions.

Authors:  E Bassenge; D J Stewart
Journal:  Z Kardiol       Date:  1986

2.  Beta-adrenergic activation of the renin-angiotensin system following alpha 2-, alpha 1-, or nonselective alpha-blockade in conscious dogs: no relation to the changes in blood pressure.

Authors:  M Saeed; J Holtz; O Sommer; G Kühne; E Bassenge
Journal:  J Cardiovasc Pharmacol       Date:  1984 Jul-Aug       Impact factor: 3.105

3.  Observations on coronary conductance artery vasomotion by induction angiometry and ultrasonic dimensions technique.

Authors:  E Bassenge; J Holtz; A Kolin; G Graser
Journal:  Basic Res Cardiol       Date:  1981 Sep-Oct       Impact factor: 17.165

4.  Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.

Authors:  K Strein; G Sponer; W Bartsch; B Müller-Beckmann; K Dietmann
Journal:  J Pharmacol Exp Ther       Date:  1984-06       Impact factor: 4.030

5.  Dose dependence of tolerance during treatment with mononitrates.

Authors:  M Tauchert; W Jansen; A Osterspey; M Fuchs; V Hombach; H H Hilger
Journal:  Z Kardiol       Date:  1983

6.  Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.

Authors:  G Sponer; H F Kühnle; K Strein; W Bartsch; R Endele; K Dietmann
Journal:  J Pharmacol Exp Ther       Date:  1984-01       Impact factor: 4.030

  6 in total
  3 in total

Review 1.  Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.

Authors:  S Silber
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Pharmacodynamics of organic nitrates: concluding remarks.

Authors:  J B Osnes
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Short and long-acting oral nitrates for stable angina pectoris.

Authors:  U Thadani; R J Lipicky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.